All Relations between cannabis and cannabinoids

Publication Sentence Publish Date Extraction Date Species
Maria M Steenkamp, Esther M Blessing, Isaac R Galatzer-Levy, Laura C Hollahan, William T Anderso. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. Depression and anxiety. vol 34. issue 3. 2017-12-29. PMID:28245077. although controlled research on marijuana and other cannabinoids' effects on ptsd remains limited, rapid shifts in the legal landscape may now enable such studies, potentially opening new avenues in ptsd treatment research. 2017-12-29 2023-08-13 human
Anahita Bassir Nia, Benjamin Medrano, Charles Perkel, Igor Galynker, Yasmin L Hur. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. Journal of psychopharmacology (Oxford, England). vol 30. issue 12. 2017-12-27. PMID:27462088. psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. 2017-12-27 2023-08-13 Not clear
Renata Androvicova, Jiri Horacek, Tibor Stark, Filippo Drago, Vincenzo Mical. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? Pharmacological research. vol 115. 2017-12-27. PMID:27884725. the endocannabinoid system (ecs), which is composed of the cannabinoid receptors types 1 and 2 (cb1 and cb2) for marijuana's psychoactive ingredient Δ 2017-12-27 2023-08-13 Not clear
Amir Levine, Kelly Clemenza, Moira Rynn, Jeffrey Lieberma. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure. Journal of the American Academy of Child and Adolescent Psychiatry. vol 56. issue 3. 2017-12-27. PMID:28219487. this review of the scientific literature examines the potential adult sequelae of exposure to cannabis and related synthetic cannabinoids in adolescence. 2017-12-27 2023-08-13 Not clear
Melissa E Badowsk. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer chemotherapy and pharmacology. vol 80. issue 3. 2017-12-27. PMID:28780725. a review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. 2017-12-27 2023-08-13 Not clear
Melissa E Badowsk. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer chemotherapy and pharmacology. vol 80. issue 3. 2017-12-27. PMID:28780725. oral cannabinoids (i.e., dronabinol, nabilone) containing the active component of marijuana, delta(Δ)9-tetrahydrocannabinol (thc), are available for the treatment of chemotherapy-induced nausea and vomiting (cinv) in patients with cancer who have failed to adequately respond to conventional antiemetic therapy. 2017-12-27 2023-08-13 Not clear
Iram P Rodriguez-Sanchez, Josee Guindon, Marco Ruiz, M Elizabeth Tejero, Gene Hubbard, Laura E Martinez-de-Villarreal, Hugo A Barrera-Saldaña, Edward J Dick, Anthony G Comuzzie, Natalia E Schlabritz-Loutsevitc. The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology. Neurotoxicology and teratology. vol 58. 2017-12-22. PMID:27327781. the consumption of marijuana (exogenous cannabinoid) almost doubled in adults during last decade. 2017-12-22 2023-08-13 Not clear
Kimberlei A Richardson, Allison K Hester, Gabrielle L McLemor. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system. Neurotoxicology and teratology. vol 58. 2017-12-22. PMID:27567698. prenatal cannabis exposure - the "first hit" to the endocannabinoid system. 2017-12-22 2023-08-13 Not clear
Kimberlei A Richardson, Allison K Hester, Gabrielle L McLemor. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system. Neurotoxicology and teratology. vol 58. 2017-12-22. PMID:27567698. the usage of marijuana during pregnancy perturbs the fetal endogenous cannabinoid signaling system (ecss), which is present and active from the early embryonic stage, modulating neurodevelopment and continuing this role into adulthood. 2017-12-22 2023-08-13 Not clear
Frank Park, Praveen K Potukuchi, Hamid Moradi, Csaba P Kovesd. Cannabinoids and the kidney: effects in health and disease. American journal of physiology. Renal physiology. vol 313. issue 5. 2017-12-19. PMID:28747360. consumption of cannabis and various related products (cannabinoids) for both medicinal and recreational use is gaining popularity. 2017-12-19 2023-08-13 Not clear
Ling-Yi Feng, Altansuvd Battulga, Eunyoung Han, Heesun Chung, Jih-Heng L. New psychoactive substances of natural origin: A brief review. Journal of food and drug analysis. vol 25. issue 3. 2017-12-19. PMID:28911631. for example, synthetic cannabinoids and synthetic cathinones are derived from the cannabis and khat plant, respectively. 2017-12-19 2023-08-13 human
David E Mandelbaum, Suzanne M de la Mont. Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed. Pediatric neurology. vol 66. 2017-12-18. PMID:27789118. the literature and reported case provide strong evidence that chronic cannabis abuse causes cognitive impairment and damages the brain, particularly white matter, where cannabinoid 1 receptors abound. 2017-12-18 2023-08-13 Not clear
Robert Ramer, Burkhard Hin. Cannabinoids as Anticancer Drugs. Advances in pharmacology (San Diego, Calif.). vol 80. 2017-12-18. PMID:28826542. other cannabinoids such as the nonpsychoactive cannabidiol exert a comparatively good safety profile while exhibiting considerable anticancer properties. 2017-12-18 2023-08-13 Not clear
Ethan B Russo, Jahan Marc. Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads. Advances in pharmacology (San Diego, Calif.). vol 80. 2017-12-18. PMID:28826544. medical and recreational consumers alike have long believed in unique attributes of certain cannabis chemovars despite their similarity in cannabinoid profiles. 2017-12-18 2023-08-13 Not clear
Justine Renard, Walter J Rushlow, Steven R Laviolett. What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 61. issue 6. 2017-12-08. PMID:27254841. ▵-9-tetrahydrocannabinol (thc), the psychoactive component of marijuana, acts as a partial agonist of cb1 cannabinoid receptors (cb1rs). 2017-12-08 2023-08-13 rat
Kathleen L Egan, Jennifer Toller Erausquin, Jeffrey J Milroy, David L Wyric. Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes. Journal of psychoactive drugs. vol 48. issue 3. 2017-12-07. PMID:27224428. males, current drinkers, and athletes who used hookah and marijuana in the past 30 days were more likely to use synthetic cannabinoids. 2017-12-07 2023-08-13 Not clear
Mauro Maccarron. Need for Methods to Investigate Endocannabinoid Signaling. Methods in molecular biology (Clifton, N.J.). vol 1412. 2017-12-07. PMID:27245886. endocannabinoids (ecbs) are endogenous lipids able to activate cannabinoid receptors, the primary molecular targets of the cannabis (cannabis sativa) active principle Δ(9)-tetrahydrocannabinol. 2017-12-07 2023-08-13 human
Cuneyt Evren, Hanife Yilmaz Cengel, Muge Bozkurt, Bilge Evren, Gokhan Umut, Ruken Agachanl. Psychometric Properties of the Turkish Versions of the Cannabis Use Problems Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ). Journal of psychoactive drugs. vol 49. issue 1. 2017-12-07. PMID:28195831. cannabis and synthetic cannabinoids are widely used illicit substances in turkey. 2017-12-07 2023-08-13 human
Cuneyt Evren, Hanife Yilmaz Cengel, Muge Bozkurt, Bilge Evren, Gokhan Umut, Ruken Agachanl. Psychometric Properties of the Turkish Versions of the Cannabis Use Problems Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ). Journal of psychoactive drugs. vol 49. issue 1. 2017-12-07. PMID:28195831. the aim of this study was to evaluate the psychometric properties of the cupit and cpq among turkish male outpatients with cannabis (n = 52) and synthetic cannabinoid (n = 45) use disorder. 2017-12-07 2023-08-13 human
Cuneyt Evren, Hanife Yilmaz Cengel, Muge Bozkurt, Bilge Evren, Gokhan Umut, Ruken Agachanl. Psychometric Properties of the Turkish Versions of the Cannabis Use Problems Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ). Journal of psychoactive drugs. vol 49. issue 1. 2017-12-07. PMID:28195831. the turkish version of the cupit and the cpq can effectively identify substance use problems and treatment outcome, respectively, among outpatients with cannabis or synthetic cannabinoid use disorder. 2017-12-07 2023-08-13 human